Multiple sclerosis
Tobacco smoking is known to increase the risk of developing multiple sclerosis (MS), but its effects on MS progression are less clear. Healy et al. performed a longitudinal follow-up study on 1,465 patients with clinically definite MS, 257 of whom were current smokers. The study showed that the disease progressed more rapidly from a relapsing–remitting course to a secondary progressive course in the smokers than in patients who had never smoked.
Healy, B. C. et al. Smoking and disease progression in multiple sclerosis. Arch. Neurol. 66, 817–818 (2009).
Epilepsy
Fattal-Valevski et al. have examined the long-term neurological consequences of thiamine deficiency in seven children in Israel, all of whom had been fed with a defective soy-based formula during infancy. As well as exhibiting mental retardation and motor disabilities, the children all developed myoclonic or complex partial seizures. These findings indlcate that epilepsy can result from severe infantile thiamine deficiency.
Spinal cord injury
Peng et al. have shown that Brilliant blue G (BBG), a compound derived from a commonly used blue food coloring, has neuroprotective effects when administered to rats after spinal cord injury. BBG antagonizes P2X7 receptors, which become activated as a result of ATP release from damaged tissue. The investigators propose that administration of BBG could represent a viable approach to the treatment of spinal cord injury in humans.
Peng, W. et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc. Natl Acad. Sci. USA 106, 12489–12493 (2009).
Migraine
Migraine auras are proposed to be caused by cortical spreading depression, and a new study lends support to this idea. In a randomized, double-blind, placebo-controlled crossover study, Hauge et al. showed that tonabersat, a drug that inhibits cortical spreading depression, had a preventative effect against aura attacks with or without headache, but not against migraine attacks without aura.
Hauge, A. W. et al. Effects of tonabersat on migraine with aura: a randomized, double-blind, placebo-controlled crossover study. Lancet Neurol. 8, 718–723 (2009).
Rights and permissions
About this article
Cite this article
In brief. Nat Rev Neurol 5, 464 (2009). https://doi.org/10.1038/nrneurol.2009.128
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2009.128